Browse the evidence

Chronic tissue inflammation, driven by obesity-induced macrophage accumulation and proinflammatory cytokine release, is a major etiologic cause of insulin resistance and beta-cell dysfunction in metabolic disease.

In obesity, fat tissue doesn't just store energy; it becomes inflamed, releasing chemicals that block insulin from working properly in your muscles, liver, and pancreas. This inflammation is a direct cause of Type 2 Diabetes risk. Managing metabolic health requires addressing this underlying inflammatory state, not just caloric intake.

Chronic inflammation in pancreatic islets, driven by macrophage infiltration and proinflammatory cytokines (IL-1β, IL-23, IL-24), causes beta-cell dysfunction and reduced glucose-stimulated insulin secretion (GSIS) in Type 2 Diabetes.

In Type 2 Diabetes, inflammation inside the pancreas damages the insulin-producing beta cells. This isn't just about insulin resistance; the pancreas itself gets inflamed, reducing its ability to secrete insulin when needed. Protecting beta cells from inflammation is a key therapeutic target.

Higher skeletal muscle membrane unsaturation, specifically increased A5 desaturase activity and higher levels of long-chain polyunsaturated fatty acids (C20-22 PUFA), is associated with improved insulin action (glucose disposal) and lower adiposity.

This research suggests that the types of fats you eat influence the structure of your muscle cell membranes. Specifically, diets that support higher levels of polyunsaturated fatty acids (PUFAs) and the enzymes that create them (like A5 desaturase) are linked to better insulin sensitivity. While this study doesn't prescribe a specific diet, it implies that dietary fat quality (specifically the ability to form long-chain PUFAs) is a lever for metabolic health.

Growth Hormone (GH) injections do not increase muscle strength in sarcopenic patients and are associated with frequent side effects.

Do not use Growth Hormone injections to treat sarcopenia. They do not improve strength and cause side effects. Focus on exercise instead.

Reduced signaling of the Growth Hormone/Insulin-Like Growth Factor (GH/IGF-I) system extends longevity and delays aging in mammals, primarily through enhanced insulin sensitivity, reduced oxidative stress, and increased stress resistance.

Current research in long-lived mouse models suggests that lower levels of Growth Hormone and IGF-I signaling are associated with extended longevity and delayed aging. While GH therapy is marketed for anti-aging, genetic evidence points to reduced signaling as the beneficial pathway. This does not currently translate to a recommended intervention for healthy humans, but highlights the importance of metabolic health and insulin sensitivity.

Soy protein improves insulin sensitivity and reduces hepatic lipogenesis by downregulating SREBP-1 and upregulating PPAR-alpha pathways.

Soy protein may help manage fat storage at a cellular level by reducing the genes responsible for making fat (SREBP-1) and increasing those responsible for burning fat (PPAR-alpha). This suggests soy protein is metabolically favorable for managing obesity-related metabolic syndrome.

Psychosocial stress and depression enhance postprandial inflammation and metabolic dysregulation (postprandial lipemia) by altering vagal tone, slowing triglyceride clearance, and increasing proinflammatory cytokine production.

Manage stress levels to mitigate their negative impact on post-meal metabolism. Stress can increase inflammation and slow the clearance of fats from your blood after eating. Techniques to reduce stress may help improve metabolic health after meals.

Acquired obesity in humans is characterized by a significant down-regulation of mitochondrial branched-chain amino acid (BCAA) catabolism in subcutaneous fat, leading to elevated serum BCAA levels that correlate with insulin resistance and liver fat accumulation.

This research suggests that in early acquired obesity, your fat tissue stops breaking down branched-chain amino acids (found in protein) efficiently. This leads to higher levels of these amino acids in your blood, which may drive insulin resistance. While this doesn't prescribe a specific diet, it highlights that metabolic health involves more than just total calories; the specific handling of amino acids by fat tissue matters.

Acquired obesity in humans is associated with the up-regulation of inflammatory pathways in subcutaneous fat, including the overexpression of osteopontin (SPP1), which correlates with insulin resistance and liver fat.

This research suggests that in early acquired obesity, your fat tissue stops breaking down branched-chain amino acids (found in protein) efficiently. This leads to higher levels of these amino acids in your blood, which may drive insulin resistance. While this doesn't prescribe a specific diet, it highlights that metabolic health involves more than just total calories; the specific handling of amino acids by fat tissue matters.

Advanced paternal age is associated with decreased sperm parameters (except concentration), increased DNA fragmentation, and higher risk of genetic disorders in offspring.

As men age, sperm quality declines, DNA fragmentation increases, and the risk of genetic disorders in children rises. Couples with advanced paternal age should be counseled cautiously regarding ART success rates and potential genetic risks.

Standard diagnostic tests (fasting glucose, HbA1c, OGTT) fail to identify glucose dysregulation in a significant subset of individuals classified as normoglycemic, who exhibit severe postprandial glucose variability and spikes into prediabetic/diabetic ranges when monitored via continuous glucose monitoring (CGM).

Standard blood tests (A1C, fasting glucose) can miss hidden glucose spikes. If you are 'normal' on labs but have risk factors, consider Continuous Glucose Monitoring (CGM) or standardized meal challenges to see how your body actually responds to food. This can reveal 'severe glucotypes' that indicate higher risk for diabetes and heart disease despite normal static labs.

Insomnia is associated with a substantial and statistically significant increased risk for the subsequent development of major depressive disorder, with insomnia often predating the onset of depression.

If you suffer from chronic insomnia, recognize that it is a significant risk factor for developing depression, not just a nuisance. The risk is substantial (approx 5x higher relative risk). Prioritizing sleep treatment is a critical preventive health measure for your mental health, as insomnia often precedes depressive episodes.

Primary insomnia is characterized by a state of hyperarousal across cognitive, physiological, and behavioral domains, including elevated HPA axis activity, autonomic dominance, and increased cortical EEG beta activity.

Insomnia is not just 'bad luck' or 'sensitivity to noise'; it is a physiological state of hyperarousal involving your stress hormones, brain activity, and heart rate. Effective treatment must address this internal arousal state, not just the environment.

In the context of dietary obesity, activation of Hif1α in visceral white adipocytes suppresses fatty acid oxidation and energy expenditure by transcriptionally repressing Sirt2, thereby maintaining obesity and associated metabolic pathologies.

This research highlights that in states of severe obesity, visceral fat tissue can become hypoxic, triggering biological mechanisms (Hif1a/Sirt2) that actively suppress fat burning and maintain fat stores. This suggests that for some individuals, obesity is not just a passive accumulation of energy but an active biological state that may require addressing underlying tissue health or hypoxia, rather than just caloric restriction alone.

Low birth weight (≤2.5 kg) is associated with higher adult fasting glucose, insulin, HOMA, and diabetes prevalence in women, and higher leptin levels and leptin-to-fat-mass ratio in both genders.

If you were born with low birth weight, you may have higher baseline leptin levels and insulin resistance compared to those born with normal weight, even if you are not overweight. This increases your risk for type 2 diabetes and cardiovascular disease. Focus on maintaining a healthy weight, regular physical activity, and monitoring blood sugar levels, as your body may be more sensitive to insulin resistance.

Repeated exposure to severe intermittent hypoxia (simulating obstructive sleep apnea) for 14 nights causes a sustained elevation in daytime blood pressure and increased muscle sympathetic nerve activity in healthy humans, driven by reduced baroreflex inhibition.

If you have sleep apnea, even if you feel healthy, the repeated drops in oxygen at night can raise your blood pressure and stress your nervous system during the day. This happens because your body's natural braking system for blood pressure (baroreflex) becomes less effective, leading to higher sympathetic activity. Treating sleep apnea is crucial to prevent this sustained daytime blood pressure elevation.

Exposure to ecologically relevant dim light (5 lux) at night increases body mass and white adipose tissue in mice, independent of total caloric intake.

If you sleep with lights on, even dim ones, your body may gain weight even if you eat the same amount. Try to keep your sleeping environment as dark as possible to support healthy metabolism.

Dim light at night disrupts circadian clock gene expression in the hypothalamus and liver, attenuating the amplitude of Per1, Per2, and Rev-Erb rhythms.

Your internal body clock relies on darkness. Dim light at night can weaken the signals that regulate your metabolism, even if you don't feel tired.

Neck circumference (NC) is uniquely associated with the prevalence of common carotid artery (CCA) plaque in diabetic adults, independent of other abdominal obesity indices.

Measuring neck circumference is a simple, low-cost screening tool for diabetic patients to assess the risk of carotid artery plaque. Clinicians should incorporate NC measurements into routine diabetes care to identify patients at higher risk for vascular complications, especially since it provides unique information not captured by waist circumference or BMI.

Age-related declines in insulin sensitivity are driven by increased adiposity rather than chronological age itself.

If you are experiencing worsening insulin sensitivity as you age, focus on managing body fat rather than accepting it as inevitable. This study suggests that maintaining a healthy body weight and composition is more critical for metabolic health than your age number.

Women have higher insulin sensitivity but lower muscle mitochondrial ATP production rates compared to men.

Women may have a metabolic advantage in insulin sensitivity compared to men, despite having lower mitochondrial ATP production rates. This suggests that metabolic health cannot be judged solely by mitochondrial capacity or muscle mass.

Chronic hyperglycemia induces oxidative stress via multiple metabolic pathways (polyol, AGE, PKC, hexosamine), which directly causes insulin resistance and beta-cell dysfunction, leading to Type 2 Diabetes.

Managing blood sugar levels is critical not just for immediate comfort, but to prevent the cellular oxidative stress that drives long-term complications like nerve and kidney damage. Focus on dietary strategies that minimize glucose spikes to reduce the metabolic burden on your cells.

Central brain GLP-1 receptor activation during hyperglycemia induces muscle insulin resistance and increases insulin secretion, thereby redirecting glucose flux to favor hepatic glycogen storage over muscle glycogen storage.

Brain GLP-1 signaling acts as a switch during high blood sugar states to prioritize liver glycogen storage over muscle storage. This is achieved by increasing insulin secretion and inducing temporary muscle insulin resistance. This mechanism prepares the body for the next fasting period by ensuring liver glycogen is replenished. This effect is specific to hyperglycemic conditions and does not occur during normal blood sugar levels.

Blockade of central GLP-1 receptors using the antagonist Exendin 9–39 (Ex9) improves glucose tolerance and fasting glycemia in diabetic mice fed a high-fat diet.

In a diabetic state induced by high-fat diet, blocking central GLP-1 receptors with Ex9 for one month normalized fasting blood sugar and improved glucose tolerance. This suggests that the central GLP-1 pathway may contribute to metabolic dysfunction in obesity/diabetes, and its blockade can have therapeutic benefits in this specific context.